Novartis, Pharmacor resolve suit over Gilenya patents

Ben Mee 2022-11-14 1:42 pm By Cat Fredenburgh

Please login to bookmark

Novartis and and generic drug maker Pharmacor have resolved litigation over the Swiss pharmaceutical giant’s patents for blockbuster MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au